Variety and Complexity of Chromosome 17 Translocations in Neuroblastoma

Genes Chromosomes and Cancer

Volumn 39, Issue 2, 2004, Pages 143-150

  Schleiermacher, Gudrun ^a   Raynal, Virginie ^a   Janoueix Lerosey, Isabelle ^a   Combaret, Valérie ^b   Aurias, Alain ^a   Delattre, Olivier ^a  

^a INSTITUT CURIE   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ALLELE; ARTICLE; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION 17; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DISRUPTION; GENE FUSION; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; KARYOTYPING; NEUROBLASTOMA; TRANSLOCATION, GENETIC;

EID: 0346096791     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10313     Document Type: Article

References (24)

1. Bown N. 2001. Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 54:897-910.
2. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F. 1999. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340:1954-1961.
3. Brinkschmidt C, Christiansen H, Terpe, HJ, Simon R, Boecker W, Lampert F, Stoerkel S. 1997. Comparative genomic hybridization (CGH) analysis of neuroblastomas-an important methodological approach in paediatric tumour pathology. J Pathol 181:394-400.
4. Brodeur GM. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
5. Caron H, van Sluis P, van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R. 1994. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
6. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Vinikoor N, Weisband J. 1984. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44:5444-5449.
7. Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voute TP, Schwab M, Versteeg R, Caron HN. 2002. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 21:2097-2101.
8. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A. 2000. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623.
9. Janoueix-Lerosey I, Penther D, Thioux M, de Cremoux P, Derre J, Ambros P, Vielh P, Benard J, Aurias A, Delattre O. 2000. Molecular analysis of chromosome arm 17q gain in neuroblastoma. Genes Chromosomes Cancer 28:276-284.
10. Keshelava N, Zuo JJ, Chen P, Waidvaratne SN, Luna MC, Gomer CJ, Triche TJ, Reynolds CP. 2001. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 61:6185-6193.
11. Lastowska M, Roberts P, Pearson AD, Lewis I, Wolstenholme J, Bown N. 1997. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer 19:143-149.
12. Lastowska M, Van Roy N, Bown N, Speleman F, Lunec J, Strachan T, Pearson AD, Jackson MS. 1998. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines. Genes Chromosomes Cancer 23:116-122.
13. Lastowska M, Cullinane C, Varind S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson ADJ, Jackson M. 2001. Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol 19:3080-3090.
14. Lastowska M, Cotterill S, Bown N, Cullinane C, Variend S, Lunec J, Strachan T, Pearson AD, Jackson MS. 2002. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosomes Cancer 34:428-436.
15. Meddeb M, Danglot G, Chudoba I, Venuat AM, Benard J, Avet-Loiseau H, Vasseur B, Le Paslier D, Terrier-Lacombe MJ, Hartmann O, Bernheim A. 1996. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 17:156-165.
16. Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML, Kallioniemi A. 2001. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98:5711-5716.
17. Savelyeva L, Corvi R, Schwab M. 1994. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
18. Schleiermacher G, Janoueix-Lerosey I, Combaret V, Derre J, Couturier J, Aurias A, Delattre O. 2003. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates pre-dominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet 141:32-42.
19. Trakhtenbrot L, Cohen N, Betts DR, Niggli FK, Amariglio N, Brok-Simoni F, Rechavi G, Meitar D. 2002. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events? Cancer Genet Cytogenet 137:95-101.
20. Tweddle DA, Malcolm AJ, Cole M, Pearson AD, Lunec J. 2001. p53 Cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol 158:2067-2077.
21. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F. 1994. 1;17 Translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10:103-114.
22. Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F. 1995. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer 31:530-535.
23. Van Roy N, Laureys G, van Gele M, Opdenakker G, Miura R, van der Drift P, Chan A, Versteeg R, Speleman F. 1997. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes. Eur J Cancer 33:1974-1978.
24. Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, Van Der Spek P, Henderson MA, Gish K, Venter DJ, Armes JE. 2003. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers. Genes Chromosomes Cancer 36:382-392.